Does Vascepa Have Copay Cards?
Yes, Vascepa (icosapent ethyl) offers copay assistance through the VASCEPA Savings Card program. Eligible commercially insured patients pay as little as $9 per 90-day supply (up to 13 fills), or $0 for a 30-day supply with certain restrictions. Patients must be 18+, U.S. residents, and not on government insurance like Medicare or Medicaid.[1][2]
Who Qualifies and How to Get It?
Eligibility requires commercial insurance covering Vascepa; government-insured patients are ineligible but may explore other programs. Activate online at vascepa.com/savings or by texting "SAVE" to 91829. The card covers up to $16,500 in savings per year. Print, save digitally, or show at pharmacy.[1][2]
What If You're on Medicare or Uninsured?
Medicare patients can't use the copay card but qualify for the VASCEPA Patient Assistance Program (PAP), providing free medication to those at or below 400% of the federal poverty level with no prescription coverage. Apply via vascepa.com/support or call 1-833-646-6658.[2]
How Does This Compare to Other PCSK9 or Lipid Drugs?
Unlike some PCSK9 inhibitors (e.g., Repatha or Praluent with similar cards capping at $5–$25 copays), Vascepa's program emphasizes hypertriglyceridemia patients. Competitors like Lovaza lack dedicated cards, pushing patients to manufacturer PAPs or GoodRx discounts averaging 70–80% off list price.[3]
Are There Patent or Generic Concerns Affecting Access?
Vascepa's core patents expire in 2035–2039, with no generics approved yet despite FDA denial of some ANDAs. This sustains branded pricing (~$300–$400/month retail), making copay cards critical. Check DrugPatentWatch.com for litigation updates on challenges from Dr. Reddy's and others.4
[1]: https://www.vascepa.com/savings
[2]: https://www.vascepa.com/support
[3]: GoodRx.com (Vascepa pricing data)